Literature DB >> 8890991

Cranial and intracranial aspergillosis of sino-nasal origin. Report of nine cases.

A Jamjoom, S S al-Hedaithy, Z A Jamjoom, M O al-Sohaibani, S A Aziz.   

Abstract

This paper is an attempt at defining the most efficacious surgical and antifungal therapy for invasive cranial and intracranial aspergillosis, and is based on experience with nine non-immunocompromised patients treated and followed-up by the authors between 1983 and 1994; as well as on the summary of previously reported cases and advances in therapy of this condition. Depending on the degree of aspergillar involvement of the cranial base and intracranial structures, a classification, with implications for treatment and prognosis, is also proposed. Two patients had extracranial skull base erosion; whereas relentlessly progressive granulomas, mimicking malignancy, invaded the skull base and intracranial contents in seven cases. Of these seven patients with cranial and intracranial invasion, two died of acute intracranial haemorrhage due to fungal invasion of cerebral blood vessels. In two patients, complete surgical eradication of the disease proved impossible due to cavernous sinus involvement, while residual aspergillomas are still present in orbit and paranasal sinuses (PNS) in a further two patients in spite of multiple surgical procedures and prolonged antifungal chemotherapy (AFC). What appears to be a cure has been effected in one patient only. Multiple therapeutic strategies were used. Biopsy plus systemic AFC was ineffective, surgical drainage and debridement plus systemic AFC resulted in long-term survivals but no cure. Radical surgery in conjunction with systemic and local (intracavitary) AFC should be considered to improve an otherwise poor prognosis.

Entities:  

Mesh:

Year:  1996        PMID: 8890991     DOI: 10.1007/bf01411283

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  8 in total

1.  Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta.

Authors:  R M Lawrence; P D Hoeprich; F A Jagdis; N Monji; A C Huston; C P Schaffner
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

2.  Transcranial resection of tumors of the paranasal sinuses and nasal cavity.

Authors:  J B Blacklock; R S Weber; Y Y Lee; H Goepfert
Journal:  J Neurosurg       Date:  1989-07       Impact factor: 5.115

Review 3.  Infection of the central nervous system in organ transplant recipients.

Authors:  D J Conti; R H Rubin
Journal:  Neurol Clin       Date:  1988-05       Impact factor: 3.806

Review 4.  Fungal infections of the CNS.

Authors:  R W Lyons; V T Andriole
Journal:  Neurol Clin       Date:  1986-02       Impact factor: 3.806

Review 5.  Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscess: case report and review of the literature.

Authors:  P J Camarata; D L Dunn; A C Farney; R G Parker; E L Seljeskog
Journal:  Neurosurgery       Date:  1992-09       Impact factor: 4.654

Review 6.  Fungal and yeast infections of the central nervous system. A clinical review.

Authors:  J S Salaki; D B Louria; H Chmel
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

Review 7.  Stereotactic drainage of Aspergillus brain abscess with long-term survival: case report and review.

Authors:  M L Goodman; R J Coffey
Journal:  Neurosurgery       Date:  1989-01       Impact factor: 4.654

8.  Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients.

Authors:  T J Walsh; D B Hier; L R Caplan
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

  8 in total
  6 in total

1.  Chronic invasive sinus aspergillosis in immunocompetent hosts: a geographic comparison.

Authors:  Brandon J Webb; Holenarasipur R Vikram
Journal:  Mycopathologia       Date:  2010-06-23       Impact factor: 2.574

2.  Aspergillus spinal epidural abscess: A case report and review of the literature.

Authors:  Mohammad Humayun Rashid; Mohammad Nazrul Hossain; Nazmin Ahmed; Raad Kazi; Gianluca Ferini; Paolo Palmisciano; Gianluca Scalia; Giuseppe Emmanuele Umana; Samer S Hoz; Bipin Chaurasia
Journal:  J Craniovertebr Junction Spine       Date:  2022-06-13

3.  Combination therapy for chronic invasive rhinocerebral aspergillosis in a clinically immunocompetent patient.

Authors:  László Lujber; Imre Gerlinger; Adám Kuncz; József Pytel
Journal:  Curr Ther Res Clin Exp       Date:  2003-07

4.  Intracranial Aspergillus granuloma.

Authors:  C Sundaram; J M K Murthy
Journal:  Patholog Res Int       Date:  2011-12-10

5.  Invasive aspergillus sinusitis with orbitocranial extension.

Authors:  Saleh S Baeesa; Rakan F Bokhari; Khalid B Alghamdi; Hisham B Alem; Jaudah A Al-Maghrabi; Tariq A Madani
Journal:  Asian J Neurosurg       Date:  2017 Apr-Jun

Review 6.  Invasive aspergillosis of the central nervous system in immunocompetent patients in Saudi Arabia: Case series and review of the literature.

Authors:  Mahmoud S Taha; Mahmoud I Haddad; Ali A Almomen; Marwa M Abdulkader; Rami A Alhazmi
Journal:  Neurosciences (Riyadh)       Date:  2021-10       Impact factor: 0.735

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.